GlassScriptPhysician profile
James C Creech
NPI 1336190685
$545.25
in general payments reported to CMS, 2019-2025
12 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $66.64 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $116.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $116.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $95.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $89.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $62.31 | 2019-2020 | |
| Novo Nordisk INC | $45.69 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $38.05 | 2019 | |
| Amgen INC. | $25.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.47 | 2019-2020 | |
| Mylan Specialty L.P. | $13.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.58 | 2019 | |
| Medtronic Minimed, INC. | $11.42 | 2019 | |
| Glaxosmithkline, LLC. | $11.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Creech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.